Insurance coverage for GLP-1 medications is patchy and changes frequently. This guide covers what's typically covered, what requires prior authorization, and how to navigate by carrier.
Coverage by indication
| Indication | Drug | Coverage status |
|---|---|---|
| Type 2 diabetes | Ozempic, Mounjaro, Trulicity | Most commercial plans cover; PA common |
| Type 2 diabetes | Victoza | Most plans cover; tier 2 |
| Weight management | Wegovy, Zepbound, Saxenda | Variable; many plans exclude |
| CV risk reduction (BMI ≥27 + CVD) | Wegovy | Varies by plan; Medicare Part D may cover it for this indication |
| OSA (BMI ≥30 + moderate-severe OSA) | Zepbound | Some plans covering post-Dec 2024 indication |
Prior authorization criteria (typical)
- BMI ≥30, OR BMI ≥27 with at least one comorbidity.
- Documented lifestyle intervention attempt (3–12 months).
- Documented obesity-related condition.
- No contraindications.
- Some plans require step therapy.
By major carrier
If your plan excludes weight-management drugs
- Check eligibility under a different indication (CV risk reduction for Wegovy; T2D if newly diagnosed; OSA for Zepbound).
- Ask employer/HR about adding coverage next plan year.
- Consider cash-pay: compounded GLP-1 or manufacturer cash programs.
- Appeal denials; document medical necessity carefully.